Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to interferon gamma"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.830 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.740 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.708 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.690 | ||
IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.532 | ||
IRF9 | interferon regulatory factor 9 | 0.510 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.413 | Human | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.412 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.404 | ||
RXRA | retinoid X receptor, alpha | 0.398 | ||
HCK | hemopoietic cell kinase | 0.385 | Human | |
CCL2 | chemokine (C-C motif) ligand 2 | 0.384 | ||
IL2RB | interleukin 2 receptor, beta | 0.372 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.363 | ||
NMI | N-myc (and STAT) interactor | 0.337 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.320 | Human | |
IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.308 | ||
HLA-E | major histocompatibility complex, class I, E | 0.304 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.227 | ||
GBP4 | guanylate binding protein 4 | 0.217 | Mouse | |
BIRC3 | baculoviral IAP repeat containing 3 | 0.216 | ||
IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.209 | ||
B2M | beta-2-microglobulin | 0.201 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.198 | ||
IRF1 | interferon regulatory factor 1 | 0.191 | Mouse | |
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.187 | ||
HLA-F | major histocompatibility complex, class I, F | 0.187 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.174 | ||
C3 | complement component 3 | 0.162 | ||
HLA-B | major histocompatibility complex, class I, B | 0.148 | ||
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.143 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.142 | ||
GHR | growth hormone receptor | 0.141 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.137 | Human | |
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.135 | ||
IDE | insulin-degrading enzyme | 0.133 | ||
RARA | retinoic acid receptor, alpha | 0.132 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.130 | ||
IL4R | interleukin 4 receptor | 0.129 | ||
AIPL1 | aryl hydrocarbon receptor interacting protein-like 1 | 0.128 | ||
STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.125 | Human | |
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.124 | ||
IFIH1 | interferon induced with helicase C domain 1 | 0.117 | ||
KLHL20 | kelch-like 20 (Drosophila) | 0.111 | ||
PDCD6 | programmed cell death 6 | 0.110 | ||
DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 | 0.109 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.105 | ||
BLNK | B-cell linker | 0.103 | ||
HLA-A | major histocompatibility complex, class I, A | 0.102 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.099 | ||
INSR | insulin receptor | 0.099 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.094 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.094 | ||
GBP1 | guanylate binding protein 1, interferon-inducible | 0.092 | ||
GBP5 | guanylate binding protein 5 | 0.091 | Mouse | |
DPP4 | dipeptidyl-peptidase 4 | 0.091 | ||
GBP2 | guanylate binding protein 2, interferon-inducible | 0.088 | Mouse | |
PPP5C | protein phosphatase 5, catalytic subunit | 0.087 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.082 | ||
HLA-C | major histocompatibility complex, class I, C | 0.079 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.079 | Human | |
IFI16 | interferon, gamma-inducible protein 16 | 0.078 | ||
IL12RB2 | interleukin 12 receptor, beta 2 | 0.077 | ||
JAK2 | Janus kinase 2 | 0.076 | Rat | |
VCAM1 | vascular cell adhesion molecule 1 | 0.075 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.075 | Human | |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.074 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.070 | ||
IL1B | interleukin 1, beta | 0.069 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.069 | ||
RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 0.069 | ||
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.066 | ||
BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.060 | ||
CD163 | CD163 molecule | 0.059 | ||
PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.058 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.056 | Human | |
UBD | ubiquitin D | 0.056 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.056 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.054 | Human | |
SOD2 | superoxide dismutase 2, mitochondrial | 0.054 | ||
APOL6 | apolipoprotein L, 6 | 0.053 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.052 | ||
HLA-G | major histocompatibility complex, class I, G | 0.051 | ||
FZD1 | frizzled homolog 1 (Drosophila) | 0.050 | ||
PHF11 | PHD finger protein 11 | 0.048 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.046 | ||
MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 0.046 | ||
IFNGR1 | interferon gamma receptor 1 | 0.046 | ||
C1S | complement component 1, s subcomponent | 0.046 | ||
MAVS | mitochondrial antiviral signaling protein | 0.046 | ||
EEF1G | eukaryotic translation elongation factor 1 gamma | 0.046 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.045 | ||
OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.045 | ||
STAP2 | signal transducing adaptor family member 2 | 0.045 | ||
GAS7 | growth arrest-specific 7 | 0.044 | ||
PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.044 | ||
GDF9 | growth differentiation factor 9 | 0.043 | ||
NLRC5 | NLR family, CARD domain containing 5 | 0.042 | ||
PRMT6 | protein arginine methyltransferase 6 | 0.041 | ||
XAF1 | XIAP associated factor 1 | 0.041 | ||
APOL3 | apolipoprotein L, 3 | 0.041 | ||
APOL1 | apolipoprotein L, 1 | 0.040 | ||
C19orf66 | chromosome 19 open reading frame 66 | 0.040 | ||
UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.039 | ||
PGR | progesterone receptor | 0.039 | ||
TLR2 | toll-like receptor 2 | 0.038 | ||
SMN1 | survival of motor neuron 1, telomeric | 0.037 | ||
CD83 | CD83 molecule | 0.037 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.036 | Human | |
DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.036 | ||
LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.036 | ||
IL7R | interleukin 7 receptor | 0.035 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.035 | Human | |
TMEM140 | transmembrane protein 140 | 0.035 | ||
LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.035 | ||
CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 | 0.035 | ||
OPTN | optineurin | 0.034 | ||
APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.034 | ||
PLEK | pleckstrin | 0.034 | ||
SLC15A3 | solute carrier family 15, member 3 | 0.034 | ||
HR | hairless homolog (mouse) | 0.034 | ||
SLA | Src-like-adaptor | 0.034 | ||
HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.034 | ||
IL15RA | interleukin 15 receptor, alpha | 0.033 | ||
IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.033 | ||
PML | promyelocytic leukemia | 0.032 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.032 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.032 | Human | |
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.031 | ||
CFHR1 | complement factor H-related 1 | 0.031 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.030 | ||
IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.030 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.030 | ||
TYMP | thymidine phosphorylase | 0.029 | ||
ITK | IL2-inducible T-cell kinase | 0.029 | ||
BCL2A1 | BCL2-related protein A1 | 0.029 | ||
FKBP4 | FK506 binding protein 4, 59kDa | 0.029 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.029 | Human | |
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.029 | ||
TRIM21 | tripartite motif containing 21 | 0.028 | ||
HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.028 | ||
ASNS | asparagine synthetase (glutamine-hydrolyzing) | 0.028 | ||
NCK1 | NCK adaptor protein 1 | 0.028 | ||
SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.028 | ||
SNCAIP | synuclein, alpha interacting protein | 0.028 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.028 | ||
IFI44L | interferon-induced protein 44-like | 0.027 | ||
ZNFX1 | zinc finger, NFX1-type containing 1 | 0.027 | ||
IFI30 | interferon, gamma-inducible protein 30 | 0.027 | ||
CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.027 | ||
ENO1 | enolase 1, (alpha) | 0.027 | ||
ESR2 | estrogen receptor 2 (ER beta) | 0.027 | ||
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.026 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.026 | ||
MAPT | microtubule-associated protein tau | 0.026 | ||
IFNG | interferon, gamma | 0.026 | ||
MED25 | mediator complex subunit 25 | 0.026 | ||
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.025 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.025 | ||
C1R | complement component 1, r subcomponent | 0.025 | ||
IL10 | interleukin 10 | 0.025 | ||
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.025 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.024 | ||
SP1 | Sp1 transcription factor | 0.024 | ||
MYO6 | myosin VI | 0.024 | ||
IFI35 | interferon-induced protein 35 | 0.024 | ||
IL2RG | interleukin 2 receptor, gamma | 0.024 | ||
ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.023 | ||
SLAMF8 | SLAM family member 8 | 0.023 | ||
SAMD9L | sterile alpha motif domain containing 9-like | 0.023 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.023 | ||
PELP1 | proline, glutamate and leucine rich protein 1 | 0.023 | ||
HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.023 | ||
DDX21 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 | 0.023 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.023 | ||
TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 0.023 | ||
ND1 | NADH dehydrogenase, subunit 1 (complex I) | 0.023 | ||
MED10 | mediator complex subunit 10 | 0.023 | ||
TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.023 | ||
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.023 | ||
JAK3 | Janus kinase 3 | 0.023 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.023 | Human | |
IL6 | interleukin 6 (interferon, beta 2) | 0.023 | ||
DAXX | death-domain associated protein | 0.023 | ||
IL32 | interleukin 32 | 0.022 | ||
PARP12 | poly (ADP-ribose) polymerase family, member 12 | 0.022 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.022 | ||
MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.022 | ||
LGALS8 | lectin, galactoside-binding, soluble, 8 | 0.022 | ||
OAS1 | 2',5'-oligoadenylate synthetase 1, 40/46kDa | 0.022 | ||
VSIG4 | V-set and immunoglobulin domain containing 4 | 0.022 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.022 | Human | |
TPT1 | tumor protein, translationally-controlled 1 | 0.022 | ||
FPR3 | formyl peptide receptor 3 | 0.021 | ||
IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 0.021 | ||
SLAMF7 | SLAM family member 7 | 0.021 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.021 | ||
LITAF | lipopolysaccharide-induced TNF factor | 0.021 | ||
PRMT1 | protein arginine methyltransferase 1 | 0.021 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.021 | ||
FYB | FYN binding protein | 0.021 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.020 | Human | |
TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.020 | ||
RUNX3 | runt-related transcription factor 3 | 0.020 | ||
MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 0.020 | ||
GSK3B | glycogen synthase kinase 3 beta | 0.020 | ||
CREBBP | CREB binding protein | 0.020 | ||
MYD88 | myeloid differentiation primary response gene (88) | 0.020 | ||
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.020 | ||
HSPA1A | heat shock 70kDa protein 1A | 0.020 | ||
CASP8AP2 | caspase 8 associated protein 2 | 0.020 | ||
C1orf38 | chromosome 1 open reading frame 38 | 0.020 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.019 | ||
BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0.019 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.019 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.019 | ||
SH2B1 | SH2B adaptor protein 1 | 0.019 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.019 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.019 | ||
DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.018 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.018 | ||
SECTM1 | secreted and transmembrane 1 | 0.018 | ||
CREM | cAMP responsive element modulator | 0.018 | ||
PGK1 | phosphoglycerate kinase 1 | 0.018 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.018 | Human | |
PDCD6IP | programmed cell death 6 interacting protein | 0.018 | ||
IRF8 | interferon regulatory factor 8 | 0.018 | ||
EIF5B | eukaryotic translation initiation factor 5B | 0.018 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.018 | ||
TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.017 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.017 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.017 | ||
LRP6 | low density lipoprotein receptor-related protein 6 | 0.017 | ||
PLSCR1 | phospholipid scramblase 1 | 0.017 | ||
DOCK7 | dedicator of cytokinesis 7 | 0.017 | ||
TMEM173 | transmembrane protein 173 | 0.017 | ||
STX11 | syntaxin 11 | 0.017 | ||
LY86 | lymphocyte antigen 86 | 0.017 | ||
IL1RN | interleukin 1 receptor antagonist | 0.017 | ||
BST2 | bone marrow stromal cell antigen 2 | 0.017 | ||
AHSA1 | AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) | 0.017 | ||
HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.017 | Human | |
SELE | selectin E | 0.017 | ||
IL4 | interleukin 4 | 0.016 | ||
KYNU | kynureninase | 0.016 | ||
HSPA1B | heat shock 70kDa protein 1B | 0.016 | ||
DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.016 | ||
C16orf53 | chromosome 16 open reading frame 53 | 0.016 | ||
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.016 | ||
SQRDL | sulfide quinone reductase-like (yeast) | 0.016 | ||
HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 0.015 | ||
CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.015 | ||
CIITA | class II, major histocompatibility complex, transactivator | 0.015 | ||
OFCC1 | orofacial cleft 1 candidate 1 | 0.015 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.015 | ||
HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 0.015 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.015 | ||
WARS | tryptophanyl-tRNA synthetase | 0.015 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.015 | ||
DBNDD2 | dysbindin (dystrobrevin binding protein 1) domain containing 2 | 0.015 | ||
GLTSCR2 | glioma tumor suppressor candidate region gene 2 | 0.015 | ||
IL10RA | interleukin 10 receptor, alpha | 0.015 | ||
PDE4DIP | phosphodiesterase 4D interacting protein | 0.015 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.015 | ||
HCP5 | HLA complex P5 | 0.015 | ||
SQSTM1 | sequestosome 1 | 0.015 | ||
SH3KBP1 | SH3-domain kinase binding protein 1 | 0.015 | ||
CHUK | conserved helix-loop-helix ubiquitous kinase | 0.015 | ||
KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.015 | ||
LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.015 | ||
PKM2 | pyruvate kinase, muscle | 0.015 | ||
IRF4 | interferon regulatory factor 4 | 0.015 | ||
SNX33 | sorting nexin 33 | 0.015 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.014 | Zebrafish | |
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.014 | ||
IRF7 | interferon regulatory factor 7 | 0.014 | ||
TRIM22 | tripartite motif containing 22 | 0.014 | ||
ITGA1 | integrin, alpha 1 | 0.014 | ||
IL18BP | interleukin 18 binding protein | 0.014 | ||
HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.014 | ||
MTA2 | metastasis associated 1 family, member 2 | 0.014 | ||
EPSTI1 | epithelial stromal interaction 1 (breast) | 0.014 | ||
MTA3 | metastasis associated 1 family, member 3 | 0.014 | ||
TGS1 | trimethylguanosine synthase 1 | 0.014 | ||
LRRK2 | leucine-rich repeat kinase 2 | 0.014 | ||
ISG20 | interferon stimulated exonuclease gene 20kDa | 0.014 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.014 | ||
DARS | aspartyl-tRNA synthetase | 0.014 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.014 | ||
CD247 | CD247 molecule | 0.014 | ||
MVP | major vault protein | 0.014 | ||
EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.014 | ||
RNF213 | ring finger protein 213 | 0.014 | ||
SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.014 | ||
EGFR | epidermal growth factor receptor | 0.014 | ||
EP300 | E1A binding protein p300 | 0.013 | ||
AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.013 | ||
PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.013 | ||
COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.013 | ||
NNMT | nicotinamide N-methyltransferase | 0.013 | ||
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.013 | ||
BECN1 | beclin 1, autophagy related | 0.013 | ||
YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.013 | Human | |
PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.013 | ||
SHISA5 | shisa homolog 5 (Xenopus laevis) | 0.013 | ||
CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.013 | ||
SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.013 | ||
RBMX | RNA binding motif protein, X-linked | 0.013 | ||
ETV7 | ets variant 7 | 0.013 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.013 | ||
SMAD9 | SMAD family member 9 | 0.013 | ||
CH25H | cholesterol 25-hydroxylase | 0.013 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.013 | ||
SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.013 | ||
ALDOA | aldolase A, fructose-bisphosphate | 0.013 | ||
PRDM1 | PR domain containing 1, with ZNF domain | 0.013 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.013 | ||
SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.013 | ||
TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.013 | ||
CFB | complement factor B | 0.013 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.013 | ||
THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.013 | ||
IL8 | interleukin 8 | 0.013 | ||
TAPBP | TAP binding protein (tapasin) | 0.013 | ||
SELL | selectin L | 0.013 | ||
MED28 | mediator complex subunit 28 | 0.013 | ||
IL23A | interleukin 23, alpha subunit p19 | 0.013 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.013 | ||
DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.013 | ||
LY6E | lymphocyte antigen 6 complex, locus E | 0.012 | ||
FKBP5 | FK506 binding protein 5 | 0.012 | ||
A1BG | alpha-1-B glycoprotein | 0.012 | ||
ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.012 | ||
LDHA | lactate dehydrogenase A | 0.012 | ||
HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.012 | ||
IRF2 | interferon regulatory factor 2 | 0.012 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.012 | ||
NCOA3 | nuclear receptor coactivator 3 | 0.012 | ||
CD69 | CD69 molecule | 0.012 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.012 | ||
UVRAG | UV radiation resistance associated gene | 0.012 | ||
STX5 | syntaxin 5 | 0.012 | ||
CCND3 | cyclin D3 | 0.012 | ||
MAPK3 | mitogen-activated protein kinase 3 | 0.012 | ||
LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.012 | ||
UBE2Z | ubiquitin-conjugating enzyme E2Z | 0.012 | ||
CXCL16 | chemokine (C-X-C motif) ligand 16 | 0.012 | ||
OASL | 2'-5'-oligoadenylate synthetase-like | 0.012 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.012 | ||
PPARG | peroxisome proliferator-activated receptor gamma | 0.012 | ||
SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.012 | ||
BCL2 | B-cell CLL/lymphoma 2 | 0.012 | ||
CLIC2 | chloride intracellular channel 2 | 0.012 | ||
MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.012 | ||
AQP9 | aquaporin 9 | 0.012 | ||
DARC | Duffy blood group, chemokine receptor | 0.011 | ||
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.011 | ||
NRG1 | neuregulin 1 | 0.011 | ||
NOS2 | nitric oxide synthase 2, inducible | 0.011 | ||
SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.011 | ||
IL12RB1 | interleukin 12 receptor, beta 1 | 0.011 | ||
CYLD | cylindromatosis (turban tumor syndrome) | 0.011 | ||
NINJ1 | ninjurin 1 | 0.011 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.011 | ||
TP53BP2 | tumor protein p53 binding protein, 2 | 0.011 | ||
TBK1 | TANK-binding kinase 1 | 0.011 | ||
LARS | leucyl-tRNA synthetase | 0.011 | ||
ABI3 | ABI family, member 3 | 0.011 | ||
FUS | fused in sarcoma | 0.011 | ||
AIM2 | absent in melanoma 2 | 0.011 | ||
TARDBP | TAR DNA binding protein | 0.011 | ||
RALBP1 | ralA binding protein 1 | 0.011 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.011 | ||
PPIA | peptidylprolyl isomerase A (cyclophilin A) | 0.011 | ||
HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.011 | ||
ALOX5 | arachidonate 5-lipoxygenase | 0.011 | ||
EVC2 | Ellis van Creveld syndrome 2 | 0.011 | ||
SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.011 | ||
SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.011 | ||
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.011 | Human | |
PLA1A | phospholipase A1 member A | 0.011 | ||
EMP3 | epithelial membrane protein 3 | 0.011 | ||
CCDC117 | coiled-coil domain containing 117 | 0.011 | ||
PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.011 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.011 | ||
ELMO1 | engulfment and cell motility 1 | 0.011 | ||
CTSS | cathepsin S | 0.011 | ||
STK10 | serine/threonine kinase 10 | 0.011 | ||
TNF | tumor necrosis factor | 0.011 | ||
IL1A | interleukin 1, alpha | 0.011 | ||
BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.011 | ||
HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.011 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.011 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
IARS | isoleucyl-tRNA synthetase | 0.011 | ||
CP | ceruloplasmin (ferroxidase) | 0.011 | ||
CLEC10A | C-type lectin domain family 10, member A | 0.011 | ||
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.011 | Human | |
S100A11 | S100 calcium binding protein A11 | 0.011 | ||
LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.011 | ||
LGALS9 | lectin, galactoside-binding, soluble, 9 | 0.011 | ||
TEC | tec protein tyrosine kinase | 0.011 | ||
COMMD6 | COMM domain containing 6 | 0.011 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.011 | ||
CFI | complement factor I | 0.011 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.011 | ||
GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.010 | ||
SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.010 | ||
IL18R1 | interleukin 18 receptor 1 | 0.010 | ||
C5AR1 | complement component 5a receptor 1 | 0.010 | ||
LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.010 | ||
NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.010 | Human | |
HSPA8 | heat shock 70kDa protein 8 | 0.010 | ||
SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.010 | ||
AARS | alanyl-tRNA synthetase | 0.010 | ||
CLEC2B | C-type lectin domain family 2, member B | 0.010 | ||
SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.010 | ||
TLR8 | toll-like receptor 8 | 0.010 | ||
TRIM38 | tripartite motif containing 38 | 0.010 | ||
APOL2 | apolipoprotein L, 2 | 0.010 | ||
TNS3 | tensin 3 | 0.010 | ||
RPL10 | ribosomal protein L10 | 0.010 | ||
GNLY | granulysin | 0.010 | ||
BATF | basic leucine zipper transcription factor, ATF-like | 0.010 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.010 | ||
RHBDF2 | rhomboid 5 homolog 2 (Drosophila) | 0.010 | ||
MED6 | mediator complex subunit 6 | 0.010 | ||
MED13 | mediator complex subunit 13 | 0.010 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.010 | ||
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.010 | ||
PPIG | peptidylprolyl isomerase G (cyclophilin G) | 0.010 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.010 | ||
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.010 | ||
CD1C | CD1c molecule | 0.010 | ||
NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.010 | ||
SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.010 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.010 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.010 | ||
CTSL1 | cathepsin L1 | 0.010 | ||
NRIP1 | nuclear receptor interacting protein 1 | 0.010 | ||
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.010 | ||
IL13 | interleukin 13 | 0.010 | ||
TCP10L | t-complex 10 (mouse)-like | 0.010 |